287 related articles for article (PubMed ID: 32084599)
1. Double-crosslinked nanocomposite hydrogels for temporal control of drug dosing in combination therapy.
Wu C; Liu J; Zhai Z; Yang L; Tang X; Zhao L; Xu K; Zhong W
Acta Biomater; 2020 Apr; 106():278-288. PubMed ID: 32084599
[TBL] [Abstract][Full Text] [Related]
2. Catechol-metal coordination-mediated nanocomposite hydrogels for on-demand drug delivery and efficacious combination therapy.
Dai G; Sun L; Xu J; Zhao G; Tan Z; Wang C; Sun X; Xu K; Zhong W
Acta Biomater; 2021 Jul; 129():84-95. PubMed ID: 34010690
[TBL] [Abstract][Full Text] [Related]
3. In vivo anti-tumor effect through the controlled release of cisplatin from biodegradable gelatin hydrogel.
Konishi M; Tabata Y; Kariya M; Suzuki A; Mandai M; Nanbu K; Takakura K; Fujii S
J Control Release; 2003 Oct; 92(3):301-13. PubMed ID: 14568411
[TBL] [Abstract][Full Text] [Related]
4. Intraperitoneal Administration of a Cisplatin-Loaded Nanogel through a Hybrid System Containing an Alginic Acid-Based Nanogel and an
Yamaguchi K; Hiraike O; Iwaki H; Matsumiya K; Nakamura N; Sone K; Ohta S; Osuga Y; Ito T
Mol Pharm; 2021 Nov; 18(11):4090-4098. PubMed ID: 34662129
[TBL] [Abstract][Full Text] [Related]
5. Injectable hydrogel imbibed with camptothecin-loaded mesoporous silica nanoparticles as an implantable sustained delivery depot for cancer therapy.
Min Jung J; Lip Jung Y; Han Kim S; Sung Lee D; Thambi T
J Colloid Interface Sci; 2023 Apr; 636():328-340. PubMed ID: 36638572
[TBL] [Abstract][Full Text] [Related]
6. Enzyme-mediated fabrication of nanocomposite hydrogel microneedles for tunable mechanical strength and controllable transdermal efficiency.
Chi Y; Zheng Y; Pan X; Huang Y; Kang Y; Zhong W; Xu K
Acta Biomater; 2024 Jan; 174():127-140. PubMed ID: 38042262
[TBL] [Abstract][Full Text] [Related]
7. In situ Co-Delivery of Doxorubicin and Cisplatin by Injectable Thermosensitive Hydrogels for Enhanced Osteosarcoma Treatment.
Si M; Xia Y; Cong M; Wang D; Hou Y; Ma H
Int J Nanomedicine; 2022; 17():1309-1322. PubMed ID: 35345787
[TBL] [Abstract][Full Text] [Related]
8. Injectable and self-healing nanocomposite hydrogel loading needle-like nano-hydroxyapatite and graphene oxide for synergistic tumour proliferation inhibition and photothermal therapy.
Qi Y; Qian Z; Yuan W; Li Z
J Mater Chem B; 2021 Dec; 9(47):9734-9743. PubMed ID: 34787633
[TBL] [Abstract][Full Text] [Related]
9. Co-delivery of IL-12 cytokine gene and cisplatin prodrug by a polymetformin-conjugated nanosystem for lung cancer chemo-gene treatment through chemotherapy sensitization and tumor microenvironment modulation.
Sun Y; Yang J; Yang T; Li Y; Zhu R; Hou Y; Liu Y
Acta Biomater; 2021 Jul; 128():447-461. PubMed ID: 33894351
[TBL] [Abstract][Full Text] [Related]
10. Preparation of FA-targeted magnetic nanocomposites co-loading TFPI-2 plasmid and cis-platinum and its targeted therapy effects on nasopharyngeal carcinoma.
Liu F; Chen B; Chen W; Chen S; Ma D; Xie M
Int J Med Sci; 2021; 18(11):2355-2365. PubMed ID: 33967612
[TBL] [Abstract][Full Text] [Related]
11. Tunable porosity of covalently crosslinked alginate-based hydrogels and its significance in drug release behavior.
Siboro SAP; Anugrah DSB; Ramesh K; Park SH; Kim HR; Lim KT
Carbohydr Polym; 2021 May; 260():117779. PubMed ID: 33712135
[TBL] [Abstract][Full Text] [Related]
12. A colon-targeted podophyllotoxin nanoprodrug: synthesis, characterization, and supramolecular hydrogel formation for the drug combination.
Ha W; Zhao XB; Zhao WH; Tang JJ; Shi YP
J Mater Chem B; 2021 Apr; 9(14):3200-3209. PubMed ID: 33885624
[TBL] [Abstract][Full Text] [Related]
13. Orally ingestible medication utilizing layered double hydroxide nanoparticles strengthened alginate and hyaluronic acid-based hydrogel bead for bowel disease management.
Nguyen NT; Nguyen BT; Ho TN; Tran CD; Tran TH; Nguyen HH; Nguyen HP; Huynh NT; Li Y; Phan VHG; Thambi T
Int J Biol Macromol; 2024 Jun; 269(Pt 1):132122. PubMed ID: 38718992
[TBL] [Abstract][Full Text] [Related]
14. Modified chitosan-hyaluronic acid based hydrogel for the pH-responsive Co-delivery of cisplatin and doxorubicin.
Anirudhan TS; Mohan M; Rajeev MR
Int J Biol Macromol; 2022 Mar; 201():378-388. PubMed ID: 35033527
[TBL] [Abstract][Full Text] [Related]
15. An Injectable Nanocomposite Hydrogel Improves Tumor Penetration and Cancer Treatment Efficacy.
Luo FQ; Xu W; Zhang JY; Liu R; Huang YC; Xiao C; Du JZ
Acta Biomater; 2022 Jul; 147():235-244. PubMed ID: 35644327
[TBL] [Abstract][Full Text] [Related]
16. Effect of low aspect ratio one-dimensional nanoparticles on properties of photocrosslinked alginate nanocomposite hydrogels.
Cordero M; Ruiz C; Palacio DA; Turunen P; Rowan A; Urbano BF
Int J Biol Macromol; 2022 Apr; 204():635-643. PubMed ID: 35176322
[TBL] [Abstract][Full Text] [Related]
17. Molecular design of peptide amphiphiles for controlled self-assembly and drug release.
Liu Z; Tang X; Feng F; Xu J; Wu C; Dai G; Yue W; Zhong W; Xu K
J Mater Chem B; 2021 Apr; 9(15):3326-3334. PubMed ID: 33881438
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin-activated and hemoglobin-mediated injectable hydrogel system for antitumor chemodynamic and chemotherapy.
Tsen HT; Sun TC; Lai TK; Huang WY; Wang HC; Lu TT; Wang TW
Biomed Pharmacother; 2024 Jun; 175():116713. PubMed ID: 38735083
[TBL] [Abstract][Full Text] [Related]
19. Supramolecular Reinforcement of Polymer-Nanoparticle Hydrogels for Modular Materials Design.
Bovone G; Guzzi EA; Bernhard S; Weber T; Dranseikiene D; Tibbitt MW
Adv Mater; 2022 Mar; 34(9):e2106941. PubMed ID: 34954875
[TBL] [Abstract][Full Text] [Related]
20. Empowering hydrophobic anticancer drugs by ultrashort peptides: General Co-assembly strategy for improved solubility, targeted efficacy, and clinical application.
Gao F; Guo J; Liu S; Zhang F; Zhang Y; Wang L
J Colloid Interface Sci; 2024 Aug; 667():119-127. PubMed ID: 38631250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
